Osher Van de Voorde Investment Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
Osher Van de Voorde Investment Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2019$10,322,000
+11.7%
107,366
-0.3%
4.59%
-3.8%
Q4 2018$9,237,000
-0.3%
107,641
+0.1%
4.77%
+19.1%
Q3 2018$9,264,000
+14.7%
107,526
+0.6%
4.00%
+3.1%
Q2 2018$8,074,000
-6.1%
106,878
+0.5%
3.88%
-11.1%
Q1 2018$8,596,000
-5.7%
106,315
+0.1%
4.37%
-9.7%
Q4 2017$9,117,0000.0%106,2000.0%4.83%0.0%
Q3 2017$9,117,000
+2.5%
106,200
-0.3%
4.83%
+1.9%
Q2 2017$8,891,000
+10.1%
106,515
-2.0%
4.74%
+7.6%
Q1 2017$8,075,000
-3.4%
108,725
-5.2%
4.40%
-4.1%
Q4 2016$8,357,000
-7.9%
114,735
-0.1%
4.59%
-11.1%
Q3 2016$9,069,000
-2.6%
114,850
+1.7%
5.17%
-12.8%
Q2 2016$9,315,000
+12.1%
112,892
-1.5%
5.93%
+12.6%
Q1 2016$8,306,000
-3.1%
114,654
+15.1%
5.27%
+6.9%
Q4 2015$8,572,000
+19.4%
99,629
+27.5%
4.93%
+12.5%
Q3 2015$7,182,000
-3.1%
78,138
+3.7%
4.38%
+1.8%
Q2 2015$7,413,000
-0.1%
75,378
+0.2%
4.30%
-0.0%
Q1 2015$7,418,000
+7.0%
75,229
+0.5%
4.30%
+6.1%
Q4 2014$6,934,000
+0.1%
74,829
+1.7%
4.06%
-8.7%
Q3 2014$6,928,000
+10.3%
73,604
+1.3%
4.44%
+6.3%
Q2 2014$6,282,000
-12.0%
72,654
-13.5%
4.17%
-8.5%
Q1 2014$7,138,000
+6.0%
83,954
+0.2%
4.56%
+4.8%
Q4 2013$6,732,000
+3.4%
83,754
-1.3%
4.35%
-15.2%
Q3 2013$6,513,000
+7.5%
84,899
-0.9%
5.13%
+6.6%
Q2 2013$6,056,00085,6494.81%
Other shareholders
NOVARTIS A G shareholders Q4 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders